Abolfazl Gilani

Dr. Abolfazl Gilani

orcid
Pathology| Tehran University of Medical Sciences

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2022 in Clinical Case Reports
Verified
Journal Article
Open access
MVMahtab Vasigh
Mahtab Vasigh
MKMohammadreza Karoobi
Mohammadreza Karoobi
MMMahnaz Montazeri
Mahnaz Montazeri
GMGolnaz Moradi
Golnaz Moradi
HAHoda Asefi
Hoda Asefi
SYSeyed Mostafa Meshkati Yazd
Seyed Mostafa Meshkati Yazd
Psoas tuberculosis abscess is very rarely detected primarily without an adjacent vertebral cold abscess. Early diagnosis prevents unnecessary operations and life‐threatening complications.

6 December 2022 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
HKHanie Karimi
Hanie Karimi
RSRoham Sarmadian
Roham Sarmadian
Abolfazl GilaniAbolfazl Gilani
Abolfazl Gilani
PSPoorya Salajegheh
Poorya Salajegheh
HBHabibe Nejad Biglari
Habibe Nejad Biglari
MGMahsa Gholizadeh
Mahsa Gholizadeh
Background: Coronavirus disease 2019 can lead to rare but severe and life-threatening diseases in susceptible high-risk populations, including patients with immunodeficiency. A rare event in this report is stroke following COVID-19 disease in a patient with an immunocompromised background due to leukemia and anti-cancer treatments. Case presentation: A 6-year-old iranian girl with precursor B-cell leukemia receiving vincristine therapy presented with fever and absolute neutrophil count < 500. Her severe acute respiratory syndrome coronavirus 2 polymerase chain reaction test was positive. During hospitalization, she had abrupt onset tachypnea, reduced O2 saturation, and generalized tonic–clonic seizures treated with phenytoin and levetiracetam. Right parietal lobe ischemia was found on a brain computed tomography scan, and the cerebrospinal fluid polymerase chain reaction test was positive for severe acute respiratory syndrome coronavirus 2. Several days later, she developed lower extremity paralysis and speech impairment, so speech therapy and physiotherapy were initiated. The patient also received dexamethasone, mannitol, heparin, and remdesivir. She was discharged with enoxaparin and levetiracetam. Chemotherapy resumed 2 weeks following discharge. Her speech and walking improved after 10 months of follow-up, and bone marrow aspiration showed total remission. Conclusion: Owing to the link between coronavirus disease 2019 and hematologic cancers with hypercoagulopathy and the tendency of patients with leukemia to have coronavirus disease 2019 complications, children with leukemia as well as suspected coronavirus disease 2019 must be hospitalized to prevent blood clot formation.

28 February 2023 in IDCases
Verified
Journal Article
Open access
HRHamidreza Rouientan
Hamidreza Rouientan
Abolfazl GilaniAbolfazl Gilani
Abolfazl Gilani
RSRoham Sarmadian
Roham Sarmadian
MRMohammad Rezaei Zadeh Rukerd
Mohammad Rezaei Zadeh Rukerd
As one of the most lethal infections caused by fungi, pulmonary mucormycosis usually affects patients who are immunocompromised. Isolated pulmonary mucormycosis in immunocompetent patients is very rare.This report describes a 65-year-old immunocompetent man, who was first treated with antibiotics after being diagnosed with a lung infection, then after the lack of response to treatment, he was diagnosed with mucormycosis in further investigations. Finally, the patient died due to a lack of response to treatment. Despite its rarity, it is important to consider other differential diagnoses such as pulmonary mucormycosis if the pneumonic process does not respond to medical treatment.

25 April 2023 in Clinical Case Reports
Verified
Journal Article
Open access
FSFaranak Salajegheh
Faranak Salajegheh
SSSara Shafieipour
Sara Shafieipour
ZNZohre Najminejad
Zohre Najminejad
PPPouria Pourzand
Pouria Pourzand
MNMohsen Nakhaie
Mohsen Nakhaie
MRMohammad Rezaei Zadeh Rukerf
Mohammad Rezaei Zadeh Rukerf
Hepatitis A virus (HAV) has some life‐threatening extrahepatic complications, such as acute acalculous cholecystitis (AAC). We present HAV‐induced AAC in a young female, based on clinical, laboratory, and imaging findings, and conduct a literature review. The patient became irritable, which progressed to lethargy, as well as a significant decline in liver function, indicating acute liver failure (ALF). She was immediately managed in the intensive care unit with close airway and hemodynamic monitoring after being diagnosed with ALF (ICU). The patient's condition was improving, despite only close monitoring and supportive treatment with ursodeoxycholic acid (UDCA) and N‐acetyl cysteine (NAC).

22 April 2024 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
RSRoham Sarmadian
Roham Sarmadian
Abolfazl GilaniAbolfazl Gilani
Abolfazl Gilani
SMSaba Mehrtabar
Saba Mehrtabar
SKSona Mahrokhi Koushemehr
Sona Mahrokhi Koushemehr
ZHZahra Hakimzadeh
Zahra Hakimzadeh
PYParsa Yousefichaijan
Parsa Yousefichaijan
Introduction: Kidney damage can result from various factors, leading to structural and functional changes in the kidney. Acute kidney injury (AKI) refers to a sudden decline in kidney function, while chronic kidney disease involves a gradual deterioration lasting more than 3 months. Mechanisms of renal injury include impaired microcirculation, inflammation, and oxidative stress. Cysteinyl-leukotrienes (CysLTs) are inflammatory substances contributing to tissue damage. Montelukast, a leukotriene receptor antagonist, has shown potential renoprotective effects in experimental models of kidney injury. Methods: The authors conducted a scoping review using PubMed, Scopus, and Web of Science databases to identify relevant studies investigating the impact of montelukast on renal diseases. Articles published until 2022 were included and evaluated for quality. Data extraction and analysis were performed based on predetermined inclusion criteria. Results: The scoping review included 30 studies from 8 countries. Montelukast demonstrated therapeutic effects in various experimental models of nephrotoxicity and AKI induced by agents such as cisplatin, lipopolysaccharide, diclofenac, amikacin, Escherichia coli, cyclosporine, methotrexate, cobalt-60 gamma radiation, doxorubicin, and cadmium. Studies involving human subjects with nephrotic syndrome, pyelonephritis, and other renal diseases also reported positive outcomes with montelukast treatment. Montelukast exhibited anti-inflammatory, anti-apoptotic, antioxidant, and neutrophil-inhibiting properties, leading to improved kidney function and histopathological changes. Conclusions: Montelukast shows promise as a renoprotective medication, particularly in early-stage kidney injury. Its ability to mitigate inflammation, oxidative stress, and neutrophil infiltration contributes to its therapeutic effects. Further research is needed to explore the clinical applications and mechanisms underlying the renoprotective action of montelukast.

28 December 2022 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
Abolfazl GilaniAbolfazl Gilani
Abolfazl Gilani
RSRoham Sarmadian
Roham Sarmadian
MKManijeh Kahbazi
Manijeh Kahbazi
PYParsa Yousefichaijan
Parsa Yousefichaijan
Bckground: Edwardsiella tarda, an Enterobacteriaceae family member, is prevalent in different aquatic settings and rarely infects humans. As a result of eating raw or undercooked seafood, humans become infected through their intestinal tracts. Extraintestinal infections have been reported infrequently, mostly in immunocompromised and chronically ill patients. Case presentation: Our report describes a case of urinary tract infection caused by E. tarda in a 4-year-old female patient with a history of urinary tract infection and a complaint of fever, dysuria, and frequency. E. tarda was identified as the pathogen isolated from the urine culture. The patient's symptoms were alleviated after receiving ceftriaxone and then nitrofurantoin. Conclusion: This case demonstrates that even in immunocompetent patients, E. tarda can infect extraintestinal organs, including urinary tract. Our patient represents the first case of E. tarda infection in Iran and due to the fact that this pathogen is transmitted by aquatic animals, there is a possibility of infecting more aquatic animals and humans in Iran; therefore, the necessary precautions should be taken.